1. Home
  2. VRAX vs SLE Comparison

VRAX vs SLE Comparison

Compare VRAX & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.66

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$0.86

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
SLE
Founded
2013
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.1M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
VRAX
SLE
Price
$0.66
$0.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$5.00
AVG Volume (30 Days)
14.7M
387.6K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,986.00
$11,568,000.00
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
$28.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.77
52 Week High
$3.20
$33.20

Technical Indicators

Market Signals
Indicator
VRAX
SLE
Relative Strength Index (RSI) 69.02 34.05
Support Level $0.39 $0.77
Resistance Level $0.43 $1.00
Average True Range (ATR) 0.06 0.12
MACD 0.02 0.08
Stochastic Oscillator 55.35 16.65

Price Performance

Historical Comparison
VRAX
SLE

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: